Brokerages Set Alteryx Inc (NYSE:AYX) PT at $92.09

Alteryx Inc (NYSE:AYX) has earned a consensus recommendation of “Buy” from the fifteen research firms that are currently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $95.42.

AYX has been the topic of several recent research reports. Needham & Company LLC upped their price target on Alteryx to $108.00 and gave the stock a “buy” rating in a report on Thursday, May 2nd. Bank of America restated a “buy” rating and set a $105.00 price target (up previously from $90.00) on shares of Alteryx in a report on Thursday, May 2nd. Citigroup upped their price objective on Alteryx from $85.00 to $93.00 and gave the stock a “buy” rating in a research report on Friday, March 1st. Zacks Investment Research raised Alteryx from a “hold” rating to a “buy” rating and set a $101.00 price objective for the company in a research report on Wednesday, May 8th. Finally, Goldman Sachs Group assumed coverage on Alteryx in a research report on Friday, June 7th. They set a “buy” rating and a $111.00 price objective for the company.

NYSE AYX traded up $8.68 during trading hours on Wednesday, hitting $104.46. 3,086,747 shares of the company were exchanged, compared to its average volume of 1,169,840. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.58 and a quick ratio of 1.58. Alteryx has a 52-week low of $34.80 and a 52-week high of $107.08. The company has a market cap of $6.07 billion, a price-to-earnings ratio of -522.30, a price-to-earnings-growth ratio of 40.97 and a beta of 1.06.

Alteryx (NYSE:AYX) last issued its quarterly earnings results on Wednesday, May 1st. The company reported ($0.02) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.16) by $0.14. Alteryx had a negative return on equity of 4.90% and a negative net margin of 2.84%. The company had revenue of $76.02 million for the quarter, compared to the consensus estimate of $71.41 million. During the same quarter in the prior year, the business earned ($0.01) EPS. Alteryx’s revenue was up 51.0% on a year-over-year basis. Equities research analysts anticipate that Alteryx will post 0.17 earnings per share for the current fiscal year.

In other news, Director Charles Cory sold 5,714 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $88.55, for a total transaction of $505,974.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Christopher M. Lal sold 13,002 shares of the company’s stock in a transaction dated Thursday, March 21st. The shares were sold at an average price of $85.00, for a total value of $1,105,170.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 99,930 shares of company stock valued at $8,786,523. Insiders own 19.82% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Cooper Haims Advisors LLC acquired a new stake in shares of Alteryx in the 1st quarter valued at about $509,000. Ibex Investors LLC boosted its position in shares of Alteryx by 19.4% in the 4th quarter. Ibex Investors LLC now owns 4,200 shares of the company’s stock valued at $250,000 after purchasing an additional 682 shares during the period. Assenagon Asset Management S.A. acquired a new stake in shares of Alteryx in the 1st quarter valued at about $4,976,000. Legal & General Group Plc boosted its position in shares of Alteryx by 3.4% in the 4th quarter. Legal & General Group Plc now owns 4,541 shares of the company’s stock valued at $270,000 after purchasing an additional 149 shares during the period. Finally, Hamilton Lane Advisors LLC boosted its position in shares of Alteryx by 493.6% in the 1st quarter. Hamilton Lane Advisors LLC now owns 79,777 shares of the company’s stock valued at $6,691,000 after purchasing an additional 66,337 shares during the period. 64.24% of the stock is owned by hedge funds and other institutional investors.

Alteryx Company Profile

Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, and citizen data scientists worldwide. Its software platform includes Alteryx Designer, a data profiling, preparation, blending, and analytics product used to create visual workflows or analytic processes; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications.

Further Reading: Cost of Equity For A Business, Investors

Analyst Recommendations for Alteryx (NYSE:AYX)

Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.